HOME >> BIOLOGY >> NEWS
Enzyme delivered in smaller package protects cells from radiation damage

SEATTLE, June 1 A University of Pittsburgh School of Medicine research team, collaborating with scientists from Stanford University, have developed a new, smaller gene therapy vector that may be effective in delivering a radioprotective enzyme systemically throughout the body which may spare healthy tissue the long-term consequences of therapeutic irradiation. These results are being presented at the 10th annual meeting of the American Society of Gene Therapy, being held May 30 to June 3 at the Washington State Convention & Trade Center, Seattle.

Combined with intensive chemotherapy, high dose whole-body irradiation often is given to patients with blood and lymphatic cancers to wipe out their bone marrow cells prior to subsequent transplantation of hematopoietic stem cells, bone marrow stem cells or peripheral blood progenitor stem cells. However, there is increasing concern that such high doses of radiation may have long-term negative effects on healthy tissues and organs, such as the kidney, liver and thyroid gland.

Based on previous studies showing that intravenous gene therapy delivery of the enzyme manganese superoxide dismutase (MnSOD) could protect mice from whole body irradiation, and in preparation for a potential clinical trial of systemic MnSOD in humans, the University of Pittsburgh and Stanford researchers, led by Joel S. Greenberger, M.D., professor and chair of the department of radiation oncology, University of Pittsburgh School of Medicine, delivered the human MnSOD enzyme into mouse hematopoietic progenitor cells using a newly constructed gene therapy vector called a "minicircle" plasmid.

To determine if the cells transfected with the MnSOD minicircle plasmid retained radioprotective capacity, they irradiated those cells as well as another cell line transfected with MnSOD in a full-sized plasmid. They also irradiated a parent mouse cell line that had not been transfected with MnSOD. After irradiation, the cells we
'"/>

Contact: Jim Swyers
SwyersJP@upmc.edu
412-657-4957
University of Pittsburgh Schools of the Health Sciences
1-Jun-2007


Page: 1 2

Related biology news :

1. Enzyme discovery sheds light on vitamin D
2. Enzyme Engineering XIX
3. Enzyme inhibitor produces stable disease in patients with advanced solid cell cancers
4. Enzyme shreds Alzheimers protein
5. Enzyme defect leads to hyperinsulinism
6. Eat less, weigh more? Enzyme makes lean mice susceptible to dietary fat
7. Enzyme crystal structure reveals unexpected genome repair functions
8. Enzyme inhibitors block replication of SARS virus
9. Enzyme may be target for new anti-inflammatory compounds
10. Enzyme action creates protein linked to Alzheimers disease
11. Enzyme deficiency may contribute to liver cancer, Mount Sinai research indicates

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/14/2020)... ... February 14, 2020 , ... ... that include integrated eTMF and Payment tracking, will be showcasing SimpleTrials at the ... , Since attending the SCOPE Summit last year, the SimpleTrials team has completed ...
(Date:2/11/2020)... ... February 11, 2020 , ... Modality Solutions, ... its ISO 9001:2015 registration by certification body Intertek. Modality Solutions’ Quality Manager, Hannah ... revised all existing Standard Operating Procedures (SOPs) and created ten new SOPs. Anderson ...
(Date:2/6/2020)... ... February 06, 2020 , ... Syntactx, ... device and pharmaceutical trials, announced that Ms. Dorothy Abel has joined the ... oversees the development and execution of regulatory plans designed to help clients ...
Breaking Biology News(10 mins):
(Date:1/23/2020)... ... , ... Ideal Implant CEO and President Robert S Hamas, ... American investor forums specializing in medical advancements. New technology was presented to US ... November 21, 2019 in New York City, and the Aesthetic Technology Summit in ...
(Date:1/22/2020)... ... January 21, 2020 , ... QCDx , a private biotech company ... blood draw, today announced the sale of the proprietary RareScope™ instrument to the Carole ... used in clinical cancer research. , “The RareScope can detect and isolate intact and ...
(Date:1/8/2020)... ... 08, 2020 , ... Anomet Products has introduced ... use in harsh environments inside or outside of the human body. , ... alloys to achieve specific properties such as corrosion-resistance, biocompatibility, or operation at temperatures ...
(Date:1/7/2020)... and SOMERVILLE, Mass. (PRWEB) , ... January 06, ... ... Murrow Center for a Digital World at The Fletcher School at Tufts University, ... Alfred P. Sloan Foundation. The grant will be administered by Tufts University, and ...
Breaking Biology Technology:
Cached News: